Both in Pharmaceuticals
Eledon Pharmaceuticals vs Cartesian Therapeutics
Over the past year ELDN returned −39.9% and RNAC returned −21.2%; their daily moves had a correlation of 0.11.
ELDN −39.9% RNAC −21.2%Growth of $1, one year, split-adjusted
| Metric | ELDN | RNAC |
|---|---|---|
| Price | $2.62 | $6.41 |
| Market cap | $212.9M | $193.9M |
| Today | 0.00% | +1.10% |
| 1 month | +4.8% | −10.2% |
| 6 months | −30.7% | −13.3% |
| Year to date | +73.5% | −11.1% |
| 1 year | −39.4% | −21.5% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 131.3× |
| Net cash | $88.8M | $94.8M |
| Dividend yield | — | — |
| Volatility (60d) | 61.4% | 49.0% |
| Short % of float | 9.7% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).